RMD Q2 2024 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q2 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.2B+12.5% YoY

Gross Profit

$669M57.6% margin

Operating Income

$275M23.7% margin

Net Income

$209M18.0% margin

EPS (Diluted)

$1.42

QoQ Revenue Growth

+5.5%

Cash Flow

Operating Cash Flow

$273M

Free Cash Flow

$249M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$6.9B

Total Liabilities

$2.4B

Stockholders' Equity

$4.5B

Cash & Equivalents

$210M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.0B	+12.5%
Gross Profit	$669M	$580M	+15.5%
Operating Income	$275M	$280M	-1.8%
Net Income	$209M	$225M	-7.2%

Revenue Segments

Sleep And Respiratory

$1.0B88%

Software As Service

$145M12%

Geographic Segments

Us Canada And Latin America

$669M58%

Combined Europe Asia And Other Markets

$349M30%

Sleep And Respiratory

$145M12%